Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.

Literature DB >> 17123283

Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.

Michael J Krowka¹, Michael B Fallon, David C Mulligan, Robert G Gish.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 17123283 DOI： 10.1002/lt.20975

Source DB: PubMed Journal: Liver Transpl ISSN： 1527-6465 Impact factor: 5.799

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Portopulmonary hypertension.

Authors: Ravi P Nayak; Dechun Li; George M Matuschak
Journal: Curr Gastroenterol Rep Date: 2009-02

Review 2. Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Authors: Michael J Krowka
Journal: Clin Liver Dis (Hoboken) Date: 2020-03-02

Review 3. Portopulmonary hypertension in liver transplant candidates.

Authors: Serife Savas Bozbas; Huseyin Bozbas
Journal: World J Gastroenterol Date: 2016-02-14 Impact factor: 5.742

4. Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules.

Authors: David S Goldberg; Michael B Fallon
Journal: Clin Gastroenterol Hepatol Date: 2013-02-14 Impact factor: 11.382

5. MELD exceptions for portopulmonary hypertension: current policy and future implementation.

Authors: D S Goldberg; S Batra; S Sahay; S M Kawut; M B Fallon
Journal: Am J Transplant Date: 2014-07-01 Impact factor: 8.086

6. Predictors of Waitlist Mortality in Portopulmonary Hypertension.

Authors: Michael J Krowka; Richard N Channick; Hilary M DuBrock; David S Goldberg; Norman L Sussman; Sonja D Bartolome; Zakiyah Kadry; Reena J Salgia; David C Mulligan; Walter K Kremers; Steven M Kawut
Journal: Transplantation Date: 2017-07 Impact factor: 4.939

Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.

1. Portopulmonary hypertension.

Review 2. Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Review 3. Portopulmonary hypertension in liver transplant candidates.

4. Model for end-stage liver disease-based organ allocation: managing the exceptions to the rules.

5. MELD exceptions for portopulmonary hypertension: current policy and future implementation.

6. Predictors of Waitlist Mortality in Portopulmonary Hypertension.

Review 7. Pulmonary vascular complications of liver disease.

Review 8. Management of portopulmonary hypertension: new perspectives.

Review 9. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension.

10. Sex Differences in Portopulmonary Hypertension.